Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study

IntroductionMammographic breast density is one of the strongest known risk factors for breast cancer. We present a novel technique for estimating breast density based on 3D T1-weighted Magnetic Resonance Imaging (MRI) and evaluate its performance, including for breast cancer risk prediction, relative to two standard mammographic density-estimation methods.MethodsThe analyses were based on MRI (n = 655) and mammography (n = 607) images obtained in the course of the UK multicentre magnetic resonance imaging breast screening (MARIBS) study of asymptomatic women aged 31 to 49 years who were at high genetic risk of breast cancer. The MRI percent and absolute dense volumes were estimated using our novel algorithm (MRIBview) while mammographic percent and absolute dense area were estimated using the Cumulus thresholding algorithm and also using a 21-point Visual Assessment scale for one medio-lateral oblique image per woman. We assessed the relationships of the MRI and mammographic measures to one another, to standard anthropometric and hormonal factors, to BRCA1/2 genetic status, and to breast cancer risk (60 cases) using linear and Poisson regression.ResultsMRI percent dense volume is well correlated with mammographic percent dense area (R = 0.76) but overall gives estimates 8.1 percentage points lower (P < 0.0001). Both show strong associations with established anthropometric and hormonal factors. Mammographic percent dense area, and to a lesser extent MRI percent dense volume were lower in BRCA1 carriers (P = 0.001, P = 0.010 respectively) but there was no association with BRCA2 carrier status. The study was underpowered to detect expected associations between percent density and breast cancer, but women with absolute MRI dense volume in the upper half of the distribution had double the risk of those in the lower half (P = 0.009).ConclusionsThe MRIBview estimates of volumetric breast density are highly correlated with mammographic dense area but are not equivalent measures; the MRI absolute dense volume shows potential as a predictor of breast cancer risk that merits further investigation.

[1]  J. Cuzick,et al.  Breast density and breast cancer risk factors in a high-risk population. , 2003, Breast.

[2]  Maryellen L. Giger,et al.  Computerized Texture Analysis of Mammographic Parenchymal Patterns of Digitized Mammograms1 , 2005 .

[3]  Anna Chiarelli,et al.  Body Size, Mammographic Density, and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[4]  Maryellen L. Giger,et al.  Computerized texture analysis of mammographic parenchymal patterns of digitized mammograms , 2004, CARS.

[5]  Michael Khazen,et al.  A Pilot Study of Compositional Analysis of the Breast and Estimation of Breast Mammographic Density Using Three-Dimensional T1-Weighted Magnetic Resonance Imaging , 2008, Cancer Epidemiology Biomarkers & Prevention.

[6]  N F Boyd,et al.  Automated analysis of mammographic densities and breast carcinoma risk , 1997, Cancer.

[7]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[8]  Li Lan,et al.  Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment. , 2007, Academic radiology.

[9]  Berkman Sahiner,et al.  Correlation between mammographic density and volumetric fibroglandular tissue estimated on breast MR images. , 2004, Medical physics.

[10]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[11]  S F Keevil,et al.  Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. , 2000, Magnetic resonance imaging.

[12]  Norman Boyd,et al.  A longitudinal study of the effects of menopause on mammographic features. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  Russell Davies,et al.  Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2006, Cancer research.

[14]  T. Sellers,et al.  Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) , 2000, Cancer Causes & Control.

[15]  R. Warren,et al.  Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study , 2000 .

[16]  L. Habel,et al.  Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN) , 2008, Breast Cancer Research and Treatment.

[17]  Zhimin Huo,et al.  Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. , 2002, Radiology.

[18]  I. Jacobs,et al.  BRCA1 and BRCA2 Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark , 2008, Clinical Cancer Research.

[19]  Joan Leach,et al.  Expert heads a'rolling Melissa Leach Ian , 2005, The Lancet.

[20]  Stephen W Duffy,et al.  Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[21]  Mary Wilson,et al.  Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view , 2008, Breast Cancer Research.

[22]  H A Risch,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions , 2008, British Journal of Cancer.

[23]  M. Giger,et al.  Computerized analysis of mammographic parenchymal patterns for breast cancer risk assessment: feature selection. , 2000, Medical physics.

[24]  H Rusinek,et al.  Fatty and fibroglandular tissue volumes in the breasts of women 20-83 years old: comparison of X-ray mammography and computer-assisted MR imaging. , 1997, AJR. American journal of roentgenology.

[25]  Y. Li,et al.  Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist , 2006, Science.

[26]  Sheila Prindiville,et al.  Effect of Raloxifene on Mammographic Density and Breast Magnetic Resonance Imaging in Premenopausal Women at Increased Risk for Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.